HOME >> MEDICINE >> NEWS
Canadian researchers discover a natural defence mechanism for Alzheimer's disease

A team from the Faculty of Medicine at Universit Laval and the research centre at CHUQ (Centre hospitalier universitaire de Qubec) has discovered a natural defence mechanism that the body deploys to combat nerve cell degeneration observed in persons with Alzheimer's disease (AD). Investigators Alain R. Simard, Denis Soulet, Genevieve Gowing, Jean-Pierre Julien and Serge Rivest describe this major discovery in the February 16th issue of the scientific journal Neuron.

Alzheimer's disease is characterized by the accumulation of amyloid proteins in the brain. These proteins form plaques around which microglia, the central nervous system's immune cells, aggregate. These microglia appear to be incapable of eliminating the plaques, and this has led some researchers to postulate that microglial action produces an inflammation causing neuronal death. The fact that Alzheimer's patients are prescribed anti-inflammatory drugs results from this concept of the disease.

For Serge Rivest and his team, whose research is funded by the Canadian Institutes of Health Research (CIHR), microglia are not part of the problem, but of its solution. These investigators have observed that, although the brain's resident microglia do appear to be poorly equipped for combating amyloid plaques, an entirely different case prevails for another type of microglia: those derived from bone marrow stem cells.

Using tests conducted with transgenic mouse models of AD, the investigators have demonstrated that bone marrow-derived microglia infiltrate amyloid plaques and succeed in destroying them most efficiently. These newly-recruited immune cells are specifically attracted by the amyloid proteins that are the most toxic to nerve cells.

"The discovery made by Dr. Rivest and his team is an important step towards a new therapeutic approach to Alzheimer's disease," states Dr. Rmi Quirion, Scientific Director of the Institute of Neurosciences, Mental Health and Addiction (INMHA
'"/>

Contact: Jasmine Sharma
613-941-4563
Canadian Institutes of Health Research
16-Feb-2006


Page: 1 2

Related medicine news :

1. Managing and preventing obesity in Canadian adults and children
2. Canadian study shows bilingualism has protective effect in delaying onset of dementia by four years
3. OPICAN study in seven Canadian cities reveals prescription opioid abuse more prevalent than heroin
4. Most Canadian med school grads lack basic surgical skills
5. Canadian study demonstrates medical induction of labor increases risk of amniotic-fluid embolism
6. Health researchers working to improve the lives of the most vulnerable Canadians
7. Canadian Blood Services scientist invents potential alternative for high-demand blood product
8. First Canadian professorship in melanoma research established
9. $900,000 for first Canadian Chair in Hypertension Prevention and Control
10. CIHR launches casebooks about Canadians turning research into action
11. Sacking of Canadian Medical Association Journals editors deeply troubling

Post Your Comments:
(Date:5/23/2013)... children and adolescents with seizures involving the temporal ... problems and psychiatric illness, especially depression. Findings published ... Wiley on behalf of the International League Against ... evaluation for pediatric epilepsy patientsparticularly for those who ... epilepsy surgery. , Current medical evidence indicates ...
(Date:5/23/2013)... 23, 2013 CareAnyware , ... health and hospice software solutions, and Cornell University ... showed significant reductions in rehospitalization rates for clinically ... Carepath protocol incorporated into CareAnyware’s EMR system. Based ... which included a 39% reduction in rehospitalization rates ...
(Date:5/23/2013)... Lotus Valve, a second-generation transcatheter aortic valve implantation ... the first 60 patients in results from REPRISE ... device performance and low mortality at 30 days., ... but there are opportunities for improvement," explained lead ... and Professor of Medicine, Monash University, Melbourne, Australia. ...
(Date:5/23/2013)... Diego, CA (PRWEB) May 23, 2013 ... Medicus Ltd. (ASX: PME), announced today that they ... available on the Apple App Store*. When used in ... Platform, Visage Ease provides authorized healthcare providers simple mobile ... Touch iOS devices. , In addition to numerous enhancements ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
Breaking Medicine News(10 mins):Health News:Depression common among children with temporal lobe epilepsy 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 3Health News:Second-generation TAVI device -- Lotus Valve -- shows good performance in REPRISE II 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:How to Stay Healthy While Traveling 2
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation ... its Investigational New Drug Application (IND) to evaluate ... the U.S. Food and Drug Administration (FDA). OMS824 ... in areas of the brain linked to a ... Huntington,s disease and schizophrenia. OMS824 has shown promising ...
(Date:5/23/2013)... YORK , May 23, 2013  Echo Pharma ... committed to waive down the Acceptance Threshold from 90 ... plus one Elan Share in accordance with the terms ... the conditions summarized below. Under the terms ... acquire Elan (NYSE: ELN ) for $12.50 ...
(Date:5/23/2013)... CHERTSEY , Engeland, May 23, 2013 ... goed voor mannen met lagere urinewegsymptomen geassocieerd met BPH ... BV, de Europese dochteronderneming van Astellas Pharma Inc, gebaseerd ... : 4503), kondigde vandaag aan dat het Nederlandse ... verleend voor VESOMNI in Nederland. De handelsvergunning ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: